查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球乳房植入物市場：按性別、最終用戶、分銷管道、關鍵地區、產業趨勢和預測（2023-2035）
市場調查報告書
商品編碼
1411405

全球乳房植入物市場：按性別、最終用戶、分銷管道、關鍵地區、產業趨勢和預測（2023-2035）

Breast Implants Market, 2023-2035 - Distribution by Gender, End User, Distribution Channel and Key Geographical Regions : Industry Trends and Global Forecasts
出版日期: | 出版商: Roots Analysis | 英文 233 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2023 年，全球乳房植入物市場規模達 192 億美元，在預測期內（2023-2035 年）複合年增長率為 9.6%。

乳房植入物是塑身和美容手術中最有前途的治療選擇之一。 事實上，到 2022 年，乳房植入手術將成為世界上最受歡迎的整容手術之一，全球將進行超過 217 萬例手術。 乳房植入手術中最常用的材料是鹽水植入物和矽膠植入物。 然而，整形外科醫師使用矽膠植入物的比例較大，佔所有整形手術的17.6%。 這主要是由於矽膠植入物的交聯率高。 此外，如果植入物破裂或洩漏，凝膠也不會進入體內。 乳癌也呈現上升趨勢，佔全球每年新發癌症病例的12.5%。

隆乳手術的目的是為了改善乳房美觀。 患者可以根據自己的喜好選擇最佳的選擇。 這種治療的效果可以持續20多年。 然而，植體破裂的幾率每年增加 1%。 一些創新正在為那些尋求乳房植入手術的人提供自然的效果。 微型植入物旨在透過小切口插入乳房組織，提供更自然的效果和最大的舒適度。 一些整形外科醫生也在致力於開發輕質矽膠美容植入物，目標是減輕 30% 的重量。 乳房植入物市場是迄今為止醫學美容市場中最大的部分，預計在預測期內將加速成長。

本報告對全球乳房植入物市場進行了分析，概述了程序概述、市場基本結構和最新情況、主要市場促進和限制因素、整體市場規模趨勢展望以及細分按細分市場和地區劃分（所有5 個地區）、主要業務聯盟和資本交易（投資、併購等）的最新趨勢、當前競爭狀況、主要公司概況等。

主要細分市場

依性別

  • 男性
  • 女性

按最終使用者

  • 醫院
  • 診所/醫療水療中心、皮膚科/美容中心
  • 其他最終用戶

依分銷通路

  • 直接銷售
  • 間接銷售

依主要地區劃分

  • 北美洲（美國、加拿大、墨西哥）
  • 歐洲（英國、德國、法國、義大利、西班牙等）
  • 亞太地區（中國、韓國、日本、印度）
  • 中東/北非（土耳其、伊朗等）
  • 拉丁美洲（巴西、阿根廷等）

主要市場參與者

  • Allergan Aesthetics
  • BioPlus
  • Collplant
  • GC Aesthetics
  • Mentor
  • Polytech
  • Sientra
  • Symatese

目錄

第一章前言

第二章研究方法

第 3 章經濟趨勢和其他特定於項目的考量

第 4 章執行摘要

第 5 章簡介

  • 醫美理念
  • 醫美的演變
  • 乳房植入物
  • 假體隆乳的優點
  • 乳房植入物的副作用
  • 醫美的主要推手因素
  • 最新醫療美容技術
  • 醫學美容的主要挑戰
  • 未來前景

第六章市場狀況

  • 乳房植入物：整體市場情勢

第七章公司簡介

  • 艾爾建美學
  • 建立實驗室
  • 導師

第八章企業競爭力分析

  • 主要先決條件和參數
  • 調查方法
  • 醫美：企業競爭力分析

第 9 章夥伴關係與協作

  • 合作夥伴模式
  • 乳房植入物：夥伴關係與協作
  • 按地區分析

第十章融資與投資

  • 融資模式
  • 乳房植入物：資金與投資
  • 結論

第 11 章市場影響分析：驅動因素、限制、機會、挑戰

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場挑戰
  • 結論

第十二章全球乳房植入物市場

  • 主要假設與研究方法
  • 全球乳房植入物市場：過去趨勢（2018-2022）與未來預測（2023-2035）
  • 主要細分市場
  • 動態儀表板

第 13 章乳房植入物市場：依最終使用者劃分

  • 主要假設與研究方法
  • 乳房植入物市場：依最終使用者劃分（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第 14 章乳房植入物市場：依性別

  • 主要假設與研究方法
  • 乳房植入物市場：依性別分類（2018、2023、2035）
  • 數據測量與驗證

第 15 章乳房植入物市場：依通路劃分

  • 主要假設與研究方法
  • 乳房植入物市場：依通路劃分（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第十六章乳房植入物市場：依主要地區

  • 主要假設與研究方法
  • 乳房植入物市場：依主要地區劃分（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第十七章乳房植入產品市場

  • 主要假設與研究方法
  • 全球乳房植入產品市場：過去趨勢（2018-2022）與未來預測（2023-2035）
  • 乳房植入產品市場：依主要地區劃分（2018 年、2023 年、2035 年）
  • 數據測量與驗證

第 18 章管理見解

第十九章結論

第 20 章附錄 1：表格資料

第 21 章附錄 2：公司與組織名單

簡介目錄
Product Code: RA100470

The breast implants market is valued at USD 19.2 billion in 2023 growing at a CAGR of 9.6% during the forecast period 2023-2035.

Breast implants are one of the most promising treatment options when it comes to body enhancements and surgeries. In fact, it is interesting to know that breast augmentation was among the most popular cosmetic procedures in the world in 2022, with more than 2.17 million operations performed worldwide. The most popular materials used in breast augmentation procedures are saline implants and silicone implants. However, the use of silicone implants by plastic surgeons is more significant, accounting for 17.6 percent of all plastic surgery procedures. This is mainly due to the higher crosslinking rate in silicone implants. In addition, if the implant ruptured or leaked, the gel would not be able to enter the body. Breast cancer is also on the rise, accounting for 12.5 percent of all new yearly cancer cases worldwide.

It is worth noting that breast implants come in various shapes and textures. The purpose of these procedures is to improve breast aesthetics. Patients can choose the best option according to their preferences. The effects of this treatment can last for more than 20 years. However, the chances of implant rupture increase by 1% every year. It is worth mentioning that several innovations are being made to give natural-looking results to people who are looking for breast augmentation. Micro-implants are being developed by researchers in this field. Micro-implants are designed to be inserted into breast tissue through small incisions. They provide more natural-looking results and maximum comfort. Some plastic surgeons are also looking to develop lightweight silicone aesthetic implants. They are trying to reduce weight by 30%. The growth of the breast implant market, which is by far the largest segment of medical aesthetics market, is expected to accelerate over the forecast period.

Key Market Segments

Gender

  • Male
  • Female

End User

  • Hospitals
  • Clincs / Med Spas and Dermatology / Cosmetology Centers
  • Other end users
  • Distribution Channel

Direct Distribution

  • Indirect Distribution

Key Geographical Regions

  • North America (U.S., Canada, Mexico)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, South Korea, Japan, India)
  • Middle East and North Africa (Turkey, Iran, Rest of the Middle East and North Africa)
  • Latin America (Brazil, Argentina, Rest of the Latin America)

Research Coverage:

The report studies the breast implants market based on gender, end user, distribution channel, and key geographical regions

The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.

The report forecasts the revenue of market segments with respect to five major regions

The report provides a general overview of medical aesthetics, including breast implants, benefits and drawbacks of these procedures. Further, the chapter also covers the new technologies applied in this field.

Comprehensive analysis of the current landscape of breast implants developers considering parameters such as establishment year, company size, headquarters, application area and end user

In-depth profiles of companies offering breast implants procedures products and / or devices, focusing on company overviews, financial information (where available), offered dermal filler procedures, recent advancements, and informed future prospects.

Detailed company competitiveness evaluation of breast implants company, considering various parameters.

An analysis of partnerships established in this sector since 2018, covering merger and acquisition, distribution, commercialization, licensing, supply, product development, product and technology integration and manufacturing agreements.

A comprehensive examination of funding and investments made in breast implants companies since 2018, encompassing venture capital financing, secondary offerings, private placements, grants, debt financing, and other equity.

The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.

Key Benefits of Buying this Report:

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the breast implants market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

  • Allergan Aesthetics
  • BioPlus
  • Collplant
  • GC Aesthetics
  • Mentor
  • Polytech
  • Sientra
  • Symatese

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Introduction
  • 1.2. Project Objectives
  • 1.3. Scope of the Report
  • 1.4. Inclusions and Exclusions
  • 1.5. Key Questions Answered
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Concept of Medical Aesthetics
  • 5.3. Evolution of Medical Aesthetics
  • 5.4. Breast Implants
  • 5.5. Advantages of Breast Implants
  • 5.6. Side Effects of Breast Implants
  • 5.7. Key Growth Drivers of Medical Aesthetics
  • 5.8. Emerging Technologies in Medical Aesthetics
    • 5.8.1. Virtual Reality in Medical Aesthetics
    • 5.8.2. Augmented Reality in Medical Aesthetics
    • 5.8.3. Artificial Intelligence in Medical Aesthetics
    • 5.8.4. Telemedicine in Medical Aesthetics
  • 5.9. Key Challenges of Medical Aesthetics
  • 5.10. Future Perspectives

6. MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Breast Implants: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters (Region)
    • 6.2.4. Analysis by Location of Headquarters (Country)
    • 6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
    • 6.2.6. Analysis by Company Size and Location of Headquarters (Region)
    • 6.2.7. Analysis by Application Area
    • 6.2.8. Analysis by End-user

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Allergan Aesthetics
    • 7.2.1. Company Overview
    • 7.2.2. Financial Information
    • 7.2.3. Medical Aesthetics Portfolio
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Establishment Labs
    • 7.3.1. Company Overview
    • 7.3.2. Financial Information
    • 7.3.3. Medical Aesthetics Portfolio
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. Mentor
    • 7.4.1. Company Overview
    • 7.4.2. Medical Aesthetics Portfolio
    • 7.4.3. Recent Developments and Future Outlook

8. COMPANY COMPETITIVENESS ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Key Assumptions and Parameters
  • 8.3. Methodology
  • 8.4. Medical Aesthetics: Company Competitiveness Analysis
    • 8.4.1. Companies based in North America
    • 8.4.2. Companies based in Europe
    • 8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Breast Implants: Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Analysis by Focus Area
    • 9.3.5. Most Active Players: Analysis by Number of Partnerships
  • 9.4. Analysis by Geography
    • 9.4.1. Local and International Agreements
    • 9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS

  • 10.1. Chapter Overview
  • 10.2. Funding Models
  • 10.3. Breast Implants: Funding and Investments
    • 10.3.1. Analysis by Year of Funding
    • 10.3.2. Analysis by Amount Invested
    • 10.3.3. Analysis by Type of Funding
    • 10.3.4. Analysis by Year and Type of Funding
    • 10.3.5. Analysis by Type of Funding and Amount Invested
    • 10.3.6. Analysis by Geography
    • 10.3.7. Most Active Players
      • 10.3.7.1. Analysis by Number of Funding Instances
      • 10.3.7.2. Analysis by Amount Raised
    • 10.3.9. Analysis by Company Size and Amount Invested
    • 10.3.10. Leading Investors: Analysis by Number of Funding Instances
  • 10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 11.1. Chapter Overview
  • 11.2. Market Drivers
  • 11.3. Market Restraints
  • 11.4. Market Opportunities
  • 11.5. Market Challenges
  • 11.6. Conclusion

12. GLOBAL BREAST IMPLANTS MARKET

  • 12.1. Chapter Overview
  • 12.2. Key Assumptions and Methodology
  • 12.3. Global Breast Implants Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 12.3.1. Scenario Analysis
      • 12.3.1.1. Conservative Scenario Analysis
      • 12.3.1.2. Optimistic Scenario Analysis
  • 12.4. Key Market Segmentations
  • 12.5. Dynamic Dashboards

13. BREAST IMPLANTS MARKET, BY END-USER

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Methodology
  • 13.3. Breast Implants Market: Distribution by End-user, 2018, 2023 and 2035
    • 13.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 13.3.2. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 13.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 13.4. Data Triangulation and Validation

14. BREAST IMPLANTS MARKET, BY GENDER

  • 14.1. Chapter Overview
  • 14.2. Key Assumptions and Methodology
  • 14.3. Breast Implants Market: Distribution by Gender, 2018, 2023 and 2035
    • 14.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.4. Data Triangulation and Validation

15. BREAST IMPLANTS MARKET, BY DISTRIBUTION CHANNEL

  • 15.1. Chapter Overview
  • 15.2. Key Assumptions and Methodology
  • 15.3. Breast Implants Market, by Distribution Channel, 2015, 2023 and 2035
    • 15.3.1. Direct Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
    • 15.3.2. Indirect Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Data Triangulation and Validation

16. BREAST IMPLANTS MARKET, BY KEY GEOGRAPHICAL REGION

  • 16.1. Chapter Overview
  • 16.2. Key Assumptions and Methodology
  • 16.3. Breast Implants Market: Distribution by Key Geographical Regions, 2016, 2023 and 2035
    • 16.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.1. US: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.2. Canada: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.1.3. Mexico: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.1. UK: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.2. Germany: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.3. France: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.4. Italy: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Spain: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.2.5. Rest of the Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.1. China: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.2. South Korea Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.3. Japan: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.3.4. India: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.1. Turkey: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.2. Iran: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 16.3.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.1. Brazil: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.2. Argentina: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
      • 16.3.5.3. Rest of the Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Data Triangulation and Validation

17. BREAST IMPLANTS PRODUCT MARKET

  • 17.1. Chapter Overview
  • 17.2. Key Assumptions and Methodology
  • 17.3. Global Breast Implants Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Breast Implants Products Market, by Key Geographical Regions, 2018, 2023 and 2035
    • 17.4.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 17.4.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Data Triangulation and Validation

18. EXECUTIVE INSIGHTS

19. CONCLUSION

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS